Therapy News and Research

RSS

Breast feeding for thirteen months or more reduces mother's risk of developing rheumatoid arthritis

In the study, the longer the breast feeding period, the lower the mother's risk of developing RA in later life.

19 Jun 2007

Otosclerosis gene identified

A gene responsible for the single most common cause of hearing loss among white adults, otosclerosis, has been identified for the first time, a scientist told the annual conference of the European Society of Human Genetics in Nice, France.

19 Jun 2007

Results of Tocilizumab study

Nearly half (43.9%) of rheumatoid arthritis (RA) patients receiving tocilizumab 8mg/kg, in addition to ongoing methotrexate therapy experienced a 50% (ACR50) improvement in symptoms at 24 weeks and more than one fifth achieved a 70% symptom improvement, according to results of a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

19 Jun 2007

Analysis of steroids as a treatment for sudden hearing loss

Although steroids are the most widely used treatment for sudden hearing loss, little scientific evidence supports their use or that of any other therapies for this condition, according to a systematic review and meta-analysis both published in the June issue of Archives of Otolaryngology, Head & Neck Surgery.

19 Jun 2007

Pepsin associated with acute rejection of a lung transplant

Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant.

19 Jun 2007

Cancer stem cells similar to normal stem cells thwart anti-cancer agents

Current cancer therapies often succeed at initially eliminating the bulk of the disease, including all rapidly proliferating cells, but are eventually thwarted because they cannot eliminate a small reservoir of multiple-drug-resistant tumor cells, called cancer stem cells, which ultimately become the source of disease recurrence and eventual metastasis.

19 Jun 2007

BSD Medical files patent for 'smart bomb' delivery of chemotherapy in breast tumors

BSD Medical Corp. has filed a patent for a new non-invasive phased array breast treatment applicator developed to selectively heat breast cancer tumors.

19 Jun 2007

Researchers breach blood-brain barrier to deliver therapy

A major obstacle in the treatment of infections and other diseases of the brain is the blood-brain barrier, which prevents systemically delivered therapeutic drugs from reaching the brain.

19 Jun 2007

Patients hospitalized with pneumonia at increased risk of major heart problems

A new study suggests patients hospitalized with pneumonia may be at serious risk of new or worsening heart problems.

19 Jun 2007

Clot-buster treatment works in frostbite patients

Researchers in the United States have found that when people with frostbite were treated with a clot-busting drug commonly used to treat stroke patients, fewer amputations resulted.

19 Jun 2007

50 million Europeans suffer from neurological diseases

About 50 million people in the EU suffer from neurological diseases such as epilepsy, migraines, multiple sclerosis, Parkinson's disease, strokes and dementia.

18 Jun 2007

Researchers clarify alphaB-crystallin's role in multiple sclerosis

A protein found primarily in the lens of the eye could be the critical "tipping point" in the spiral of inflammation and damage that occurs in multiple sclerosis, researchers at the Stanford University School of Medicine report.

18 Jun 2007

Antitumor vaccine

How can we induce the body to use its own weapon, the immune system, to battle cancer" In principle, by the same means used against infectious diseases: immunization.

18 Jun 2007

Study on B-cell depletion therapy

36% of patients with refractory systemic lupus erythematosus (SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without needing further standard immunosuppressive agents, according to a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

17 Jun 2007

Early treatment with Infliximab and Methotrex shows benefit for rheumatoid arthritis

Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis (RA), according to data presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain

17 Jun 2007

Imagery rehearsal therapy helps insomniacs

In a study that insomniacs may find welcoming, imagery rehearsal therapy (IRT) has been shown to subjectively improve their ability to get a good night's sleep, according to research presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

17 Jun 2007

Aspirin resistance

Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.

17 Jun 2007

Hormone therapy can extend life in ovarian cancer patients

The study, published in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

17 Jun 2007

New area of stroke drug discovery for the 22nd century

A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.

17 Jun 2007

Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced the presentation of additional data that showed that the safety profile of Enbrel, (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

17 Jun 2007